logo
  

TCF Financial Q4 Profit Falls - Quick Facts

TCF Financial Corp. or TCF (TCB) reported lower net income attributable to the company of $24.0 million for the fourth quarter of 2014, compared with $40.0 million for the fourth quarter of 2013. Earnings per share were 12 cents, compared with 22 cents a year ago. On average, 18 analysts polled by Thomson Reuters expected earnings of 29 cents per share for the quarter. Analysts' estimates typically exclude special items.

Quarterly total revenue advanced 2.1% to $313.8 million from $307.2 million in the prior-year quarter.

Net interest income for the quarter improved 1.1 percent to $204.07 million from $201.86 million in the fourth quarter of 2013, driven by higher average loan and lease balances in the auto finance, leasing and equipment finance and inventory finance businesses, partially offset by lower average consumer real estate loan balances due to run-off, as well as continued margin reduction.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and...

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT